Table 3. Percentage neutralization of IgG1s m43, m48, m14, m18, b12, 2F5 and 4E10 at 30 µg/ml against 30 HIV-1 primary isolates from different clades in TZM-bl and PBMC-p24 assays.
Virus | Clade | Tropism | TZM-bl assay | PBMC assay | ||||||||||||||||
m9 | m14 | m18 | m43 | m48 | b12 | 2F5 | 4E10 | 21.2 | m9 | m14 | m18 | m43 | m48 | b12 | 2F5 | 4E10 | 21.2 | |||
92UG_029 | A | X4 | 99 | 56 | 30 | 0 | 0 | 95 | 97 | 91 | 99 | 34 | 0 | 0 | 0 | 0 | 95 | 31 | 9 | 42 |
93RW_024 | A | Dual | 18 | 0 | 0 | 0 | 0 | 0 | 93 | 75 | 85 | 85 | 0 | 0 | 0 | 0 | nd | 66 | 0 | 38 |
00KE_KER2008 | A | Dual | 85 | 0 | 0 | 0 | 0 | 0 | 85 | 84 | 89 | 0 | 18 | 9 | 0 | 0 | 0 | 42 | 31 | 43 |
99KE_KNH1135 | A | R5 | 14 | 0 | 11 | 20 | 3 | 100 | 92 | 83 | 73 | 96 | 29 | 32 | 64 | 69 | 95 | 81 | 93 | 75 |
00KE_KSM 4030 | A | R5 | 0 | 0 | 0 | 0 | 0 | 0 | 97 | 95 | 91 | 72 | 72 | 49 | 77 | 32 | 31 | 81 | 72 | 85 |
89BZ_167 | B | X4 | 0 | 84 | 100 | 100 | 0 | 95 | 100 | 99 | 99 | 0 | 61 | 91 | 43 | 12 | 70 | 70 | 60 | 99 |
92FR_BXO8 | B | R5 | 98 | 84 | 83 | 86 | 0 | 85 | 92 | 89 | 98 | 99 | 37 | 46 | 1 | 19 | 70 | 51 | 23 | 99 |
90US_873 | B | R5 | 93 | 30 | 18 | 22 | 0 | 100 | 99 | 93 | 96 | 79 | 0 | 45 | 60 | 47 | 93 | 96 | 89 | 99 |
96TH_NP1538 | B | R5 | 69 | 0 | 0 | 0 | 0 | 0 | 61 | 44 | 89 | 94 | 0 | 4 | 18 | 19 | nd | 84 | 39 | 85 |
91US_4 | B | R5 | 84 | 0 | 0 | 0 | 6 | 58 | 72 | 73 | 95 | 99 | 68 | 48 | 49 | 46 | 45 | 94 | 81 | 99 |
89SM_145 | C | R5 | 86 | 24 | 9 | 6 | 15 | 0 | 0 | 90 | 83 | 52 | 4 | 8 | 45 | 0 | nd | 0 | 53 | 30 |
01TZ_911 | C | R5 | 60 | 10 | 0 | 1 | 4 | 5 | 0 | 90 | 90 | 82 | 0 | 4 | 58 | 0 | nd | 0 | 0 | 29 |
98US_MSC5016 | C | R5 | 83 | 70 | 40 | 31 | 0 | 0 | 18 | 98 | 87 | 95 | 0 | 0 | 0 | 0 | nd | 0 | 0 | 0 |
94IN_20635-4 | C | R5 | 99 | 51 | 5 | 0 | 0 | 99 | 0 | 96 | 95 | 90 | 43 | 51 | 54 | 39 | 99 | 8 | 73 | 95 |
00TZ_A125 | C | R5 | 16 | 0 | 0 | 0 | 10 | 0 | 0 | 83 | 54 | 42 | 42 | 27 | 50 | 24 | 64 | 39 | 36 | 53 |
00UG_D26830M4 | D | R5 | 0 | 12 | 0 | 8 | 0 | 4 | 59 | 62 | 98 | 96 | 0 | 33 | 3 | 35 | 66 | 0 | 82 | |
93UG_065 | D | X4 | 99 | 21 | 18 | 16 | 6 | 5 | 99 | 90 | 78 | 96 | 67 | 45 | 73 | 28 | 19 | 70 | 62 | 64 |
99UG_AO8483M1 | D | R5 | 90 | 87 | 86 | 88 | 10 | 100 | 74 | 59 | 97 | 99 | 36 | 52 | 25 | 0 | 99 | 86 | 62 | 83 |
98UG_57128 | D | R5 | 94 | 65 | 60 | 65 | 16 | 100 | 1 | 70 | 86 | 92 | 60 | 40 | 59 | 26 | 98 | 10 | 56 | 50 |
00KE_NKU3006 | D | R5 | 71 | 17 | 0 | 8 | 4 | 67 | 93 | 87 | 49 | 95 | 25 | 55 | 0 | 0 | nd | 74 | 34 | 37 |
90TH_CM235 | AE | R5 | 19 | 24 | 0 | 23 | 24 | 22 | 91 | 80 | 70 | 26 | 0 | 11 | 0 | 0 | nd | 64 | 8 | 53 |
90TH_CM240 | AE | R5 | 95 | 21 | 29 | 30 | 33 | 20 | 90 | 90 | 87 | 20 | 0 | 0 | 18 | 0 | nd | 10 | 37 | 9 |
96TH_NI1149 | AE | R5 | 14 | 10 | 23 | 14 | 16 | 12 | 3 | 91 | 66 | 87 | 28 | 71 | 72 | 52 | nd | 19 | 47 | 92 |
96TH_M02138 | AE | X4 | 0 | 21 | 33 | 25 | 0 | 16 | 99 | 97 | 90 | 2 | 0 | 0 | 0 | 0 | nd | 23 | 0 | 51 |
90TH_CM244 | AE | R5 | 0 | 24 | 27 | 17 | 37 | 9 | 95 | 89 | 85 | nd | nd | nd | nd | nd | nd | nd | nd | nd |
02CM_1970LE | AG | R5 | 10 | 15 | 18 | 12 | 8 | 16 | 99 | 98 | 85 | 93 | 18 | 35 | 14 | 19 | nd | 72 | 0 | 40 |
98US_MSC5007 | AG | R5 | 91 | 9 | 13 | 15 | 0 | 5 | 74 | 83 | 78 | 87 | 23 | 28 | 52 | 32 | 40 | 93 | 74 | 81 |
02CM_ 0013BBY | AG | R5 | 58 | 9 | 16 | 24 | 5 | 6 | 0 | 90 | 73 | 94 | 51 | 42 | 45 | 66 | 67 | 70 | 66 | 72 |
02CM_0015BBY | AG | R5 | 25 | 45 | 20 | 9 | 7 | 33 | 95 | 94 | 79 | 68 | 0 | 0 | 12 | 0 | nd | 48 | 11 | 45 |
02CM_0014BBY | AG | R5 | 36 | 12 | 6 | 5 | 13 | 19 | 19 | 91 | 83 | 93 | 8 | 53 | 1 | 19 | nd | 13 | 26 | 71 |
Percentage of virus neutralized | 57 | 23 | 13 | 13 | 0 | 33 | 70 | 97 | 97 | 76 | 21 | 21 | 34 | 10 | 63 | 55 | 41 | 66 |
HIV-1-infected patient serum (pool 21.2) was included as a control. Percentage neutralization of viral infection are color coded so that the darker the color, the more potent the neutralization: a white box indicated <50% neutralization, a light grey box indicates 50%< percentage neutralization <90%, and a dark grey box indicates percentage neutralization >90%. n.d., not done.